Detection of Breast Cancer with Mammography: Effect of an Artificial Intelligence Support System.

Journal: Radiology
Published Date:

Abstract

Purpose To compare breast cancer detection performance of radiologists reading mammographic examinations unaided versus supported by an artificial intelligence (AI) system. Materials and Methods An enriched retrospective, fully crossed, multireader, multicase, HIPAA-compliant study was performed. Screening digital mammographic examinations from 240 women (median age, 62 years; range, 39-89 years) performed between 2013 and 2017 were included. The 240 examinations (100 showing cancers, 40 leading to false-positive recalls, 100 normal) were interpreted by 14 Mammography Quality Standards Act-qualified radiologists, once with and once without AI support. The readers provided a Breast Imaging Reporting and Data System score and probability of malignancy. AI support provided radiologists with interactive decision support (clicking on a breast region yields a local cancer likelihood score), traditional lesion markers for computer-detected abnormalities, and an examination-based cancer likelihood score. The area under the receiver operating characteristic curve (AUC), specificity and sensitivity, and reading time were compared between conditions by using mixed-models analysis dof variance and generalized linear models for multiple repeated measurements. Results On average, the AUC was higher with AI support than with unaided reading (0.89 vs 0.87, respectively; P = .002). Sensitivity increased with AI support (86% [86 of 100] vs 83% [83 of 100]; P = .046), whereas specificity trended toward improvement (79% [111 of 140]) vs 77% [108 of 140]; P = .06). Reading time per case was similar (unaided, 146 seconds; supported by AI, 149 seconds; P = .15). The AUC with the AI system alone was similar to the average AUC of the radiologists (0.89 vs 0.87). Conclusion Radiologists improved their cancer detection at mammography when using an artificial intelligence system for support, without requiring additional reading time. Published under a CC BY 4.0 license. See also the editorial by Bahl in this issue.

Authors

  • Alejandro Rodríguez-Ruiz
    From the Department of Radiology and Nuclear Medicine, Radboud University Medical Center, PO Box 9101, 6500 HB Nijmegen, Geert Grooteplein 10, 6525 GA, Post 766, Nijmegen, the Netherlands (A.R.R., I.S., R.M.M.); Department of Radiology & Imaging Sciences, Emory University, Atlanta, Ga (E.K.); ScreenPoint Medical BV, Nijmegen, the Netherlands (J.J.M.); Lynn Women's Health & Wellness Institute, Boca Raton Regional Hospital, Boca Raton, Fla (K.S.); Referenzzentrum Mammographie Munich, Brustdiagnostik München and FFB, Munich, Germany (S.H.H.); and Dutch Expert Centre for Screening, Nijmegen, the Netherlands (I.S.).
  • Elizabeth Krupinski
    Department of Radiology, Medical College of Georgia at Augusta University, 1120 15th St, Augusta, GA 30912 (Y.T.); and Department of Radiology, Emory University, Atlanta, Ga (B.V., E.K., A.P., J.G., N.S., H.T.).
  • Jan-Jurre Mordang
    From the Department of Radiology and Nuclear Medicine, Radboud University Medical Center, PO Box 9101, 6500 HB Nijmegen, Geert Grooteplein 10, 6525 GA, Post 766, Nijmegen, the Netherlands (A.R.R., I.S., R.M.M.); Department of Radiology & Imaging Sciences, Emory University, Atlanta, Ga (E.K.); ScreenPoint Medical BV, Nijmegen, the Netherlands (J.J.M.); Lynn Women's Health & Wellness Institute, Boca Raton Regional Hospital, Boca Raton, Fla (K.S.); Referenzzentrum Mammographie Munich, Brustdiagnostik München and FFB, Munich, Germany (S.H.H.); and Dutch Expert Centre for Screening, Nijmegen, the Netherlands (I.S.).
  • Kathy Schilling
    From the Department of Radiology and Nuclear Medicine, Radboud University Medical Center, PO Box 9101, 6500 HB Nijmegen, Geert Grooteplein 10, 6525 GA, Post 766, Nijmegen, the Netherlands (A.R.R., I.S., R.M.M.); Department of Radiology & Imaging Sciences, Emory University, Atlanta, Ga (E.K.); ScreenPoint Medical BV, Nijmegen, the Netherlands (J.J.M.); Lynn Women's Health & Wellness Institute, Boca Raton Regional Hospital, Boca Raton, Fla (K.S.); Referenzzentrum Mammographie Munich, Brustdiagnostik München and FFB, Munich, Germany (S.H.H.); and Dutch Expert Centre for Screening, Nijmegen, the Netherlands (I.S.).
  • Sylvia H Heywang-Köbrunner
    From the Department of Radiology and Nuclear Medicine, Radboud University Medical Center, PO Box 9101, 6500 HB Nijmegen, Geert Grooteplein 10, 6525 GA, Post 766, Nijmegen, the Netherlands (A.R.R., I.S., R.M.M.); Department of Radiology & Imaging Sciences, Emory University, Atlanta, Ga (E.K.); ScreenPoint Medical BV, Nijmegen, the Netherlands (J.J.M.); Lynn Women's Health & Wellness Institute, Boca Raton Regional Hospital, Boca Raton, Fla (K.S.); Referenzzentrum Mammographie Munich, Brustdiagnostik München and FFB, Munich, Germany (S.H.H.); and Dutch Expert Centre for Screening, Nijmegen, the Netherlands (I.S.).
  • Ioannis Sechopoulos
    Department of Radiology and Nuclear Medicine, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
  • Ritse M Mann
    Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.